Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Sodium Hydroxide | HCID 14798 | — |
| Reactant | 2-(Chloromethyl)-4-(3-methoxypropoxy)-3-methylpyridine | HCID 11031667 | — |
| Reactant | HCID 178527775 | HCID 178527775 | — |
| Solvent | Ethanol | HCID 702 | — |
| Product | Rabeprazole-thioether | HCID 9949996 | 101% |
Reaction Steps
2-Chloromethyl-4-(3-methoxypropoxy)-3-methylpyridine (53.2 g (200 mmol)), denatured ethanol (320 ml), 2-benzimidazole thiol (30.2 g (201 mmol)) and sodium hydroxide (26.8 g (670 mmol)) were added together and reacted for about 2 hours at 50° C. After disappearance of the raw materials had been confirmed by TLC, this solution was concentrated under a reduced pressure and ethyl acetate (430 ml) and water (340 ml) were added thereto, followed by stirring and standing, and the water layer was then separated. The organic layer was washed with 10% aqueous sodium hydroxide solution (110 ml) and water (2×110 ml) and concentrated under a reduced pressure to obtain crude 2-[{4-(3-methoxypropoxy)-3-methylpyridin-2-yl}methylthio]-1H-benzimidazole (69.0 g) (HPLC purity 98.7%, yield 101%).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08053580B2 |
|---|
| Source dataset | uspto-grants-2011_11 |
|---|
| ORD ID | ord-6fe93b4c0a374189a15c2a941c0361f7 |
|---|
| Source note | uspto-grants-2011_11 |
|---|